Skip to main content

Year: 2019

Asure Software Recognized as a Fastest Growing Company on Deloitte’s 2019 Technology Fast 500™

AUSTIN, Texas, Dec. 09, 2019 (GLOBE NEWSWIRE) — Asure Software (NASDAQ:ASUR), a leading provider of cloud-based Human Capital Management (HCM) software solutions, was recently recognized as one of North America’s Fastest Growing Companies on Deloitte’s 2019 Technology Fast 500™.Now in its 25th year, the award features the 500 fastest growing technology, media, telecommunications, life sciences, and energy tech companies in North America based on percentage fiscal year revenue growth over a three year period. Asure Software grew 231 percent during this period.  Asure’s fully-integrated HCM platform, flexible benefits and compliance administration, HR consulting, and time and labor management solutions are used by over 60,000 customers.Asure Software’s chief executive officer, Pat Goepel, attributes the company’s consistent revenue...

Continue reading

Update: Leone Asset Management Announces Closing of the Acquisition With BFA Media

Largo, FL, Dec. 09, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Today, Leone Asset Management (OTC PINK: LEON) announced the closing of the acquisition with BFA Media, Inc. (Terms were not disclosed.)James Price, CEO of Leone Asset Management, stated, “We are extremely excited to announce the closing with BFA Media.  We believe the BFA acquisition will bring tremendous shareholder value to Leone as well as add great exposure to Go Epic Health’s flagship product Cholesterade® and other products and services we own or partner with.”About Leone Asset Management Leone Asset Management, Inc., is a multi-national, multi-industry conglomerate with subsidiary companies that operate in Health and Wellness, Media & Communications, Infrastructure development, agriculture management and mining exploration. For additional information,...

Continue reading

Generex Biotechnology Provides Update on Pending Dividend

MIRAMAR, Fla., Dec. 09, 2019 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (OTCQB: GNBT) today provided guidance on the postponed stock dividend. Tomorrow, Tuesday December 10, 2019 at 9:30 AM, Generex will announce the new pay date and ex-date for the dividend and will announce a new configuration for the dividend as well as an additional benefit for shareholders.Joe Moscato, Generex President & CEO stated, “This dividend has been hampered by problems just like the first 20 to 1 dividend that Generex gave shareholders last year. The company appreciates and has a responsibility to shareholders to provide value for their investment, that is what we have delivered over the last 2 years, and I will continue to do into the future. After an extensive legal and regulatory legal review of the problems we have faced in the last...

Continue reading

ORYZON Presents New Efficacy Data From its Phase II Trial ALICE Investigating iadademstat in AML

Results presented at 61st ASH Annual Conference in Orlando, FL, USASignals of clinical efficacy continue to be encouraging, with 75% OR (6 out of 8: 2 CR, 3 CRi and 1 PR)Rapid clinical responses (mean time to first response is currently 32 days)Preliminary rate of conversion to red cell Transfusion Independence (40%) is also encouragingSafe and well tolerated, with no clinically relevant non-hematological AEsMADRID, Spain and CAMBRIDGE, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today presented new data from its ongoing Phase II trial ALICE, which is investigating iadademstat in combination with azacitidine in elderly patients with acute myeloid...

Continue reading

Hemp, Inc. CEO, Bruce Perlowin, Interviewed in CEOCFO Magazine on Leading Industrial Hemp in America

Spring Hope, NC, Dec. 09, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Hemp, Inc. (OTC PINK: HEMP) a global leader in the industrial hemp industry with bi-coastal processing centers, including the largest multipurpose industrial hemp processing facility in the western hemisphere, announced today news coverage in the outlet, CEOCFO Magazine, an independent investment publication that highlights important technologies and companies.The published article features an interview with Bruce Perlowin, CEO of Hemp, Inc., regarding a wide variety of topics, ranging from the history of Hemp, Inc., the uses of hemp and the current size of the industrial hemp market. There is also commentary on Hemp, Inc.’s industrial materials, the difference between marijuana and hemp, the Company’s growth and geographic reach. Additionally, the interview...

Continue reading

Banca IFIS group presents the three-year business plan

Banca IFIS Group presentsthe three-year Business Plan                                                                                         Milan, 9th December 2019 – Luciano Colombini, Banca IFIS’s CEO, is pleased to invite you to attend the presentation of 2020-2022 Business Plan that will take place:Tuesday, 14th January 2020at 11:00 CET Excelsior Hotel GalliaPiazza Duca d’Aosta, 9 – MilanQ&A session. The presentation will be followed by a Q&A session.After presentation a light lunch.Live Stream. If you are unable to attend, it will be possible to follow the event via live stream.Presentation material. The slide presentation will be available for downloading on our website https://www.bancaifis.it/ in the Investor Relations section, shortly before the beginning of the event.                                                                                                           Attachment20191209_Banca...

Continue reading

Il Gruppo Banca IFIS presenta il Piano Industriale triennale

Il Gruppo Banca IFISpresenta il Piano Industriale triennale                                                                                         Milano, 09 Dicembre 2019 – Luciano Colombini, amministratore delegato di Banca IFIS S.p.A., è lieto di invitare la comunità finanziaria alla presentazione del Piano Industriale 2020/2022 che si terrà:Martedì, 14 Gennaio 2020alle ore 11:00 Excelsior Hotel GalliaPiazza Duca d’Aosta, 9 – MilanoQ&A. Al termine della presentazione è prevista una Q&A session.A seguire light lunch.Diretta Live. In caso di impossibilità a partecipare, sarà possibile seguire l’evento in diretta live.Materiali. Le slide della presentazione saranno disponibili per la consultazione e il download sul sito https://www.bancaifis.it/ alla sezione Investor Relations, poco prima dell’inizio dell’evento.                                                                                                           Allegato20191209_Banca...

Continue reading

Cargotec’s Navis to acquire assets of Jade Logistics, provider of terminal operating system for mixed cargo terminals

CARGOTEC CORPORATION, PRESS RELEASE, 9 DECEMBER 2019 AT 05:10 PM (EET)Navis, a part of Cargotec Corporation, and the provider of operational technologies and services that unlock greater performance and efficiency for the world’s leading organisations across the shipping supply chain, has entered into an agreement to acquire the assets of Jade Logistics, a provider of the Master Terminal TOS for mixed cargo terminals. Jade Logistics is based in Christchurch, New Zealand and is trusted by over 100 facilities globally to manage the transport of mixed cargo such as steel, timber, containers, cars and many other materials. With N4, Octopi and Jade Master Terminal, Navis can offer the flexibility of the right TOS for any prospective customer’s cargo requirements. Navis will establish a General Cargo Center of Excellence in Christchurch, New...

Continue reading

Cargotecin Navis ostaa sekarahtiterminaalien käyttöjärjestelmää tarjoavan Jade Logisticsin liiketoiminnot

CARGOTEC OYJ, LEHDISTÖTIEDOTE, 9. JOULUKUUTA 2019 KLO 17:10Cargoteciin kuuluva Navis on sopinut ostavansa Christchurchissa Uudesta-Seelannissa toimivan Jade Logistics -yhtiön liiketoiminnot. Yhtiön sekarahtiterminaaleille tarkoitettua Master Terminal -toiminnanohjausjärjestelmää (TOS) käytetään yli 100 terminaalissa globaalisti sekarahdin, kuten teräksen, puun, konttien ja autojen hallintaan. Navis voi N4-, Octopi- ja Jade Master Terminal -tuotteidensa avulla tarjota juuri oikeanlaisen toiminnanohjausjärjestelmän erityyppisten asiakkaiden lastinkäsittelytarpeisiin. Navis perustaa General Cargo Center of Excellence -keskuksen Christchurchiin palvelemaan kasvavaa sekarahtiratkaisujen kysyntää maailmanlaajuisesti. Kaupan odotetaan toteutuvan vuoden 2019 loppuun mennessä.Jade Logisticsin oston myötä Navis pystyy entistä paremmin tukemaan ympäri...

Continue reading

Forty Seven, Inc. Announces Foundational Preclinical Data Supporting the Development of FSI-174 in Combination with Magrolimab as a Novel All Antibody Conditioning Regimen for Hematopoietic Stem Cell Transplantation

— Expect to Initiate Phase 1 Clinical Trial in Healthy Volunteers in First Quarter of 2020 —— Forty Seven to Host Investor Event and Webcast at 8:00 p.m. ET —MENLO PARK, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) — Forty Seven, Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced preclinical proof-of-concept data for its novel all antibody conditioning regimen, comprised of FSI-174, its anti-cKIT antibody, and magrolimab, its anti-CD47 antibody. Preclinical studies in a non-human primate (NHP) model showed that the combination of FSI-174 and magrolimab significantly depleted hematopoietic stem cells (HSCs) from the bone marrow, with no dose limiting toxicities. The data will be presented in a poster session...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.